Article
Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 May 2016
Gastañaduy Paul A, Steenhoff Andrew P, Mokomane Margaret, Esona Mathew D, Bowen Michael D, Jibril Haruna, Pernica Jeffrey M, Mazhani Loeto, Smieja Marek, Tate Jacqueline E, Parashar Umesh D, Goldfarb David M
Abstract excerpt
BACKGROUND: Botswana introduced monovalent G1P rotavirus vaccine (RV1) in July 2012, providing one of the first opportunities to assess the effectiveness of routine RV1 vaccination in a high-burden setting in Africa. We sought to determine the effectiveness of RV1 against rotavirus diarrhea hospitalization using a case-control evaluation. METHODS: Vaccine age-eligible children <5 years of age admitted with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.